Home
>
National Drug Code (NDC)
>
Abacavir
Abacavir - 65862-073-60 - (Abacavir Sulfate)
Drug Information of Abacavir
| Product NDC: | 65862-073 |
| Proprietary Name: | Abacavir |
| Non Proprietary Name: | Abacavir Sulfate |
| Active Ingredient(s): | 300 mg/1 & nbsp; Abacavir Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Abacavir
| Product NDC: | 65862-073 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077844 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121217 |
Package Information of Abacavir
| Package NDC: | 65862-073-60 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (65862-073-60) |
NDC Information of Abacavir
| NDC Code | 65862-073-60 |
| Proprietary Name | Abacavir |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (65862-073-60) |
| Product NDC | 65862-073 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Abacavir Sulfate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20121217 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | ABACAVIR SULFATE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
